MedTrace Logo

Screen CardRen - A Cross-sectional Observational Cohort Study

NCT06272578 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 400

Last updated 2024-08-21

No results posted yet for this study

Summary

In this single-centre, cross-sectional study, the investigators aim to assess the prevalence of asymptomatic echocardiographic structural and functional cardiac abnormalities in adult CKD patients with additional cardiovascular risk factors. Furthermore, with the use of Olink technology, analyses of the plasma proteome will be performed to identify potential protein pathways associated with early structural changes.The investigators hypothesize that protein expression will be altered in patients with prevalent echocardiographic abnormalities that indicate stage B heart failure.

Conditions

Interventions

DIAGNOSTIC_TEST

Echocardiography

Echocardiography

Sponsors & Collaborators

  • AstraZeneca

    collaborator INDUSTRY

  • Charite University, Berlin, Germany

    lead OTHER

Principal Investigators

  • Frank Edelmann, Prof. Dr. · German Heart Institute

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-03-01
Primary Completion
2025-02-27
Completion
2025-06-30

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06272578 on ClinicalTrials.gov